Table 3 Multivariable stepwise logistic regression analysis for the presence of CAD.

From: Tetranectin as a Potential Biomarker for Stable Coronary Artery Disease

Variable

OR (95% CI)

P value

Tetranectin

0.680 (0.491,0.940)

0.020*

Age

1.402 (1.184,1.660)

<0.001*

Male

0.159 (0.016,1.546)

0.113

BMI

0.775 (0.541,1.109)

0.164

Platelets

0.983 (0.963, 1.003)

0.096

Glucose

1.258 (0.472, 3.355)

0.647

ALT

1.034 (0.974, 1.098)

0.269

AST

1.018 (0.929, 1.116)

0.701

γ-GT

1.011 (0.988, 1.035)

0.357

BUN

1.882 (0.668, 5.304)

0.231

SCr

0.951 (0.916, 0.987)

0.008*

Uric acid

1.008 (0.994, 1.022)

0.265

TG

76.799 (3.368,1751.320)

0.007*

TC

0.000 (0.000,0.020)

<0.001*

HDL-C

616.687 (2.917,1.3*105)

0.019*

LDL-C

3.2*105 (96.223,1.1*107)

<0.001*

Lp(a)

5.099 (0.019,1336.635)

0.566

Smoking

0.174 (0.011,2.657)

0.209

Hypertension

0.290 (0.039,2.140)

0.225

Diabetes mellitus

1.909 (0.232,15.691)

0.547

Hyperlipidaemia

0.455 (0.048,4.304)

0.492

COPD

0 (0.000,0.020)

0.999

  1. CAD, coronary artery disease; BMI, Body Mass Index; ALT, alanine aminotransferase; AST, aspartate transaminase; γ-GT, gamma-glutamyl transpeptidase; BUN, blood urea nitrogen; SCr, serum creatinine; TG, triglycerides; TC, total cholesterol; HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-density lipoprotein-cholesterol; Lp(a), lipoprotein(a); COPD, chronic obstructive pulmonary disease.CI, confidence interval; OR, odds ratio; *P < 0.05.
Back to article page